Abstract
Panic disorder still remains a pervasive, life quality impairing disorder requiring adequate treatment options. In this case report we present the data of a patient with panic disorder and comorbid depression who was treated with high-frequency repetitive transcranial magnetic stimulation (rTMS) applied to the left prefrontal cortex over a course of 3 weeks. Measurements of the cerebral oxygenation with near-infrared spectroscopy (NIRS) during an emotional Stroop task before and after the rTMS treatment suggests that rTMS may modulate panic-related prefrontal brain dysfunctions in panic patients and that it may serve as a possible treatment option for anxiety disorders.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic Uptake Inhibitors / therapeutic use
-
Adrenergic alpha-Antagonists / therapeutic use
-
Adrenergic beta-Antagonists / therapeutic use
-
Adult
-
Amitriptyline / therapeutic use
-
Bisoprolol / therapeutic use
-
Combined Modality Therapy
-
Drug Therapy, Combination
-
GABA Modulators / therapeutic use
-
Humans
-
Male
-
Panic Disorder / drug therapy
-
Panic Disorder / therapy*
-
Sulfonamides / therapeutic use
-
Tamsulosin
-
Temazepam / therapeutic use
-
Transcranial Magnetic Stimulation / methods*
Substances
-
Adrenergic Uptake Inhibitors
-
Adrenergic alpha-Antagonists
-
Adrenergic beta-Antagonists
-
GABA Modulators
-
Sulfonamides
-
Amitriptyline
-
Temazepam
-
Tamsulosin
-
Bisoprolol